Transaction Details

Footnotes

Each performance-based restricted stock unit represents a contingent right to receive one share of MMED common stock. The performance-based restricted stock units vest on March 9, 2027, subject to MMED common stock achieving a closing price per share of at least $32.05 as of the Divestment Date (as defined in the Separation Agreement, dated March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US Holdco 2, Inc.). | The later of March 9, 2027 or the Divestment Date. | The option vests 33% on each of March 9, 2028 and March 9, 2029, and 34% on March 9, 2030.